AAAAAA
Results: 1-25/51
Authors:
Brune, K
Citation: K. Brune, The science of pharmacology: a plea for joining forces, TRENDS PHAR, 22(6), 2001, pp. 323-324
Authors:
Werner, U
Werner, D
Mundkowski, R
Gillich, M
Brune, K
Citation: U. Werner et al., Selective and rapid liquid chromatography-mass spectrometry method for thequantification of rofecoxib in pharmacokinetic studies with humans, J CHROMAT B, 760(1), 2001, pp. 83-90
Authors:
Guhring, H
Tegeder, I
Lotsch, J
Pahl, A
Werner, U
Reeh, PW
Rehse, K
Brune, K
Geisslinger, G
Citation: H. Guhring et al., Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia, INFLAMM RES, 50(2), 2001, pp. 83-88
Authors:
Krebs, S
Dormann, H
Muth-Selbach, U
Hahn, EG
Brune, K
Schneider, HT
Citation: S. Krebs et al., Risperidone-induced cholestatic hepatitis, EUR J GASTR, 13(1), 2001, pp. 67-69
Authors:
Tegeder, I
Niederberger, E
Israr, E
Guhring, H
Brune, K
Euchenhofer, C
Grosch, S
Geisslinger, G
Citation: I. Tegeder et al., Inhibition of NF-KB and AP-1 activation by R- and S-flurbiprofen, FASEB J, 15(3), 2001, pp. 595-597
Authors:
Tegeder, I
Niederberger, E
Israr, E
Guhring, H
Brune, K
Euchenhofer, C
Grosch, S
Geisslinger, G
Citation: I. Tegeder et al., Inhibition of NF-kappa B and AP-1 activation by R- and S-flurbiprofen, FASEB J, 15(1), 2001, pp. 2-4
Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages
Authors:
Hinz, B
Brune, K
Rau, T
Pahl, A
Citation: B. Hinz et al., Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages, PHARM RES, 18(2), 2001, pp. 151-156
Authors:
Brune, K
Neubert, A
Citation: K. Brune et A. Neubert, Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective, CLIN EXP RH, 19(6), 2001, pp. S51-S57
Authors:
Lotsch, J
Muth-Selbach, U
Tegeder, I
Brune, K
Geisslinger, G
Citation: J. Lotsch et al., Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate, BR J CL PH, 52(4), 2001, pp. 387-398
Authors:
Dormann, H
Krebs, S
Muth-Selbach, U
Criegee-Rieck, M
Radespiel-Troger, M
Levy, M
Hahn, EG
Brune, K
Schneider, HT
Citation: H. Dormann et al., Adverse drug reactions in patients with gastroenterological diseases: doesage increase the risk?, ALIM PHARM, 15(2), 2001, pp. 171-180
Authors:
Maihofner, C
Schlotzer-Schrehardt, U
Guhring, H
Zeilhofer, HU
Naumann, GOH
Pahl, A
Mardin, C
Tamm, ER
Brune, K
Citation: C. Maihofner et al., Expression of cyclooxygenase-1 and-2 in normal and glaucomatous human eyes, INV OPHTH V, 42(11), 2001, pp. 2616-2624
Authors:
Damm, J
Rau, T
Maihofner, C
Pahl, A
Brune, K
Citation: J. Damm et al., Constitutive expression and localization of COX-1 and COX-2 in rabbit irisand ciliary body, EXP EYE RES, 72(6), 2001, pp. 611-621
Authors:
Guhring, H
Schuster, J
Hamza, M
Ates, M
Kotalla, CE
Brune, K
Citation: H. Guhring et al., HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test, EUR J PHARM, 429(1-3), 2001, pp. 127-134
Authors:
Brugger, R
Reichel, C
Alia, BG
Brune, K
Yamamoto, T
Tegeder, I
Geisslinger, G
Citation: R. Brugger et al., Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics (vol 61, pg 651, 2001), BIOCH PHARM, 62(3), 2001, pp. 399-399
Authors:
Brugger, R
Reichel, C
Alia, BG
Brune, K
Yamamoto, T
Tegeder, I
Geissinger, G
Citation: R. Brugger et al., Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics, BIOCH PHARM, 61(6), 2001, pp. 651-656
Authors:
Ramer, R
Brune, K
Pahl, A
Hinz, B
Citation: R. Ramer et al., R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism, BIOC BIOP R, 286(5), 2001, pp. 1144-1152
Authors:
Krebs, S
Dormann, H
Hahn, EG
Schneider, HT
Brune, K
Citation: S. Krebs et al., Adverse drug reactions. Avoiding, reporting and early intervention by a computer-based sentinal system, DEUT MED WO, 125(33), 2000, pp. 984-987
Authors:
Werner, U
Brune, K
Layh, B
Guehring, H
Citation: U. Werner et al., Determination of L-iminoethyl-L-lysine in serum by liquid chromatography, J CHROMAT B, 749(1), 2000, pp. 35-40
Authors:
Hartner, A
Pahl, A
Brune, K
Goppelt-Struebe, M
Citation: A. Hartner et al., Upregulation of cyclooxygenase-1 and the PGE(2) receptor EP2 in rat and human mesangioproliferative glomerulonephritis, INFLAMM RES, 49(7), 2000, pp. 345-354
Authors:
Diener, HC
Brune, K
Gerber, WD
Pfaffenrath, V
Straube, A
Citation: Hc. Diener et al., Therapy of the acute migraine attack and migraine prophylaxis. Recommendation of the "Deutsche Migrane- und Kopfschmerz-Gesellschaft", SCHMERZ, 14(4), 2000, pp. 269-283
Authors:
Brune, K
Lemmer, B
Citation: K. Brune et B. Lemmer, Is homeopathic medicine on the same level as Diclofenac?, SCHMERZ, 14(1), 2000, pp. 33-34
Authors:
Lotsch, J
Kettenmann, B
Renner, B
Drover, D
Brune, K
Geisslinger, G
Kobal, G
Citation: J. Lotsch et al., Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: Relation to pharmacodynamics in an experimental pain model, PHARM RES, 17(1), 2000, pp. 77-84
Authors:
Diener, HC
Brune, K
Gerber, WD
Pfaffenrath, V
Straube, A
Citation: Hc. Diener et al., Therapy of migraine attack and migraine prophylaxis - Recommendations of the German Migraine and Headache Society, NERVENHEILK, 19(6), 2000, pp. 335-345
Authors:
Grosser, K
Oelkers, R
Hummel, T
Geisslinger, G
Brune, K
Kobal, G
Lotsch, J
Citation: K. Grosser et al., Olfactory and trigeminal event-related potentials in migraine, CEPHALALGIA, 20(7), 2000, pp. 621-631
Authors:
Maihofner, C
Tegeder, I
Euchenhofer, C
Dewitt, D
Brune, K
Bang, R
Neuhuber, W
Geisslinger, G
Citation: C. Maihofner et al., Localization and regulation of cyclo-oxygenase-1 and-2 and neuronal nitricoxide synthase in mouse spinal cord, NEUROSCIENC, 101(4), 2000, pp. 1093-1108